Etanercept in Alzheimer's Disease: a randomised, placebo controlled, double-blind phase 2 trial

Project Number
GH-2012563
Agency/Funding Organization
Alzheimer's Drug Discovery Foundation
Funding Year
2015
Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
CLIVE
Principal Investigator Last Name
HOLMES
Awardee Organization
Contact PI Country
Project Detail
Funding Opportunity Announcement
FY Overall Cost
$533,330
Funding Organization
Agency/Funding Organization
Funding Organization Country